HCPCS Level II drug code
J1938 — Injection, furosemide, 1 mg
In short
J1938 is the HCPCS Level II code for injection, furosemide, 1 mg. CMS assigns NDCs for Furosemide to it. One billing unit is 1 mg. The Medicare Part B payment limit is $0.018 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS fileHCPCS codeJ1938
Billing unit1 mg
- Descriptor
- Injection, furosemide, 1 mg
- Short descriptor
- Inj, furosemide, 1 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Apr 1, 2025
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP filePayment limit per unit$0.018
Per1 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 1 mg. For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J1938
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 57 NDCs to J1938 for Furosemide. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Furosemide | 00143-9155-25 | Hikma Pharmaceuticals USA Inc. | 25 × 2 | 500 |
| Furosemide | 00143-9156-10 | Hikma Pharmaceuticals USA Inc. | 10 × 4 | 400 |
| Furosemide | 00143-9157-10 | Hikma Pharmaceuticals USA Inc. | 10 × 10 | 1,000 |
| Furosemide | 00143-9158-01 | Hikma Pharmaceuticals USA Inc. | 50 | 500 |
| Furosemide | 00143-9159-01 | Hikma Pharmaceuticals USA Inc. | 100 | 1,000 |
| Furosemide | 00404-9861-10 | Henry Schein Inc. | 10 | 100 |
| Furosemide | 00404-9862-10 | Henry Schein Inc. | 10 | 100 |
| Furosemide | 00404-9863-04 | Henry Schein Inc. | 4 | 40 |
| Furosemide | 00404-9864-02 | Henry Schein Inc. | 2 | 20 |
| Furosemide | 00409-6102-02 | Pfizer Inc | 25 × 2 | 500 |
| Furosemide | 00409-6102-04 | Pfizer Inc | 25 × 4 | 1,000 |
| Furosemide | 00409-6102-10 | Pfizer Inc | 25 × 10 | 2,500 |
| Furosemide | 16729-0500-08 | Accord Healthcare Inc | 25 × 2 | 500 |
| Furosemide | 16729-0501-43 | Accord Healthcare Inc | 10 × 4 | 400 |
| Furosemide | 16729-0502-43 | Accord Healthcare Inc | 10 × 10 | 1,000 |
| Furosemide | 23155-0473-41 | Heritage Pharmaceuticals Inc. | 25 × 2 | 500 |
| Furosemide | 23155-0473-42 | Heritage Pharmaceuticals Inc. | 25 × 4 | 1,000 |
| Furosemide | 23155-0473-44 | Heritage Pharmaceuticals Inc. | 25 × 10 | 2,500 |
| Furosemide | 25021-0311-02 | Sagent Pharmaceuticals | 25 × 2 | 500 |
| Furosemide | 25021-0311-04 | Sagent Pharmaceuticals | 25 × 4 | 1,000 |
| Furosemide | 25021-0311-10 | Sagent Pharmaceuticals | 25 × 10 | 2,500 |
| Furosemide | 25021-0320-02 | Sagent Pharmaceuticals | 25 × 2 | 500 |
| Furosemide | 25021-0320-04 | Sagent Pharmaceuticals | 25 × 4 | 1,000 |
| Furosemide | 25021-0320-10 | Sagent Pharmaceuticals | 25 × 10 | 2,500 |
| Furosemide | 36000-0282-25 | Baxter Healthcare Corporation | 25 × 2 | 500 |
| Furosemide | 36000-0283-25 | Baxter Healthcare Corporation | 25 × 4 | 1,000 |
| Furosemide | 36000-0284-25 | Baxter Healthcare Corporation | 25 × 10 | 2,500 |
| Furosemide | 51662-1226-03 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 10 | 2,500 |
| Furosemide | 51662-1227-01 | HF Acquisition Co. LLC, DBA HealthFirst | 2 | 20 |
| Furosemide | 51662-1572-01 | HF Acquisition Co. LLC, DBA HealthFirst | 2 | 20 |
| Furosemide | 51662-1572-03 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 2 | 500 |
| Furosemide | 51662-1574-01 | HF Acquisition Co. LLC, DBA HealthFirst | 4 | 40 |
| Furosemide | 51662-1574-03 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 4 | 1,000 |
| Furosemide | 51662-1575-01 | HF Acquisition Co. LLC, DBA HealthFirst | 10 | 100 |
| Furosemide | 55150-0322-25 | Eugia US LLC | 25 × 2 | 500 |
| Furosemide | 55150-0323-25 | Eugia US LLC | 25 × 4 | 1,000 |
| Furosemide | 55150-0324-25 | Eugia US LLC | 25 × 10 | 2,500 |
| Furosemide | 63323-0280-02 | FreseniUS Kabi USA, LLC | 25 × 2 | 500 |
| Furosemide | 63323-0280-04 | FreseniUS Kabi USA, LLC | 25 × 4 | 1,000 |
| Furosemide | 63323-0280-10 | FreseniUS Kabi USA, LLC | 25 × 10 | 2,500 |
| Furosemide | 63323-0280-16 | FreseniUS Kabi USA, LLC | 25 × 2 | 500 |
| Furosemide | 63323-0280-26 | FreseniUS Kabi USA, LLC | 25 × 4 | 1,000 |
| Furosemide | 63323-0280-36 | FreseniUS Kabi USA, LLC | 25 × 10 | 2,500 |
| Furosemide | 70121-1076-05 | Amneal Pharmaceuticals, LLC | 25 × 10 | 2,500 |
| Furosemide | 70860-0302-02 | Athenex Pharmaceutical Division, LLC | 25 × 2 | 500 |
| Furosemide | 70860-0302-10 | Athenex Pharmaceutical Division, LLC | 25 × 10 | 2,500 |
| Furosemide | 71288-0203-03 | Meitheal Pharmaceuticals Inc. | 25 × 2 | 500 |
| Furosemide | 71288-0203-05 | Meitheal Pharmaceuticals Inc. | 25 × 4 | 1,000 |
| Furosemide | 71288-0203-11 | Meitheal Pharmaceuticals Inc. | 25 × 10 | 2,500 |
| Furosemide | 72572-0190-25 | Civica, Inc. | 25 × 4 | 1,000 |
| Furosemide | 72603-0133-25 | Northstar RxLLC | 25 × 2 | 500 |
| Furosemide | 72603-0251-25 | Northstar RxLLC | 25 × 4 | 1,000 |
| Furosemide | 72603-0474-25 | Northstar RxLLC | 25 × 10 | 2,500 |
| Furosemide | 81565-0201-02 | Phlow Corporation | 25 × 2 | 500 |
| Furosemide | 83634-0302-02 | Avenacy Inc. | 25 × 2 | 500 |
| Furosemide | 83634-0302-04 | Avenacy Inc. | 25 × 4 | 1,000 |
| Furosemide | 83634-0302-10 | Avenacy Inc. | 25 × 10 | 2,500 |
J1938: common questions
- Is J1938 a CPT code?
- No. J1938 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J1938?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 57 NDCs under J1938, for Furosemide. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J1938?
- $0.018 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J1938?
- One unit of J1938 is 1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg. J-code billing units.